Valuation: West Pharmaceutical Services, Inc.

Market Cap 27.19B 24.79B 22.83B 20.78B 38.99B 2,520B 41.1B 278B 110B 1,373B 102B 99.85B 4,310B P/E 2026 *
41.8x
P/E 2027 * 37.6x
Enterprise Value 26.69B 24.34B 22.41B 20.4B 38.27B 2,473B 40.35B 273B 108B 1,348B 100B 98.02B 4,231B EV / Sales 2026 *
7.8x
EV / Sales 2027 * 7.27x
Free-Float
92.02%
Yield 2026 *
0.24%
Yield 2027 * 0.26%
1 day-1.61%
1 week-6.27%
Current month-5.41%
1 month-0.81%
3 months+10.54%
6 months+23.46%
Current year+41.86%
1 week 387.71
Extreme 387.71
420.66
1 month 386.88
Extreme 386.88
438.27
Current year 223.83
Extreme 223.83
438.27
1 year 223.83
Extreme 223.83
438.27
3 years 187.43
Extreme 187.43
438.27
5 years 187.43
Extreme 187.43
475
10 years 77.97
Extreme 77.97
475.35
Manager TitleAgeSince
Chief Executive Officer 52 2026-08-30
Director of Finance/CFO 57 2025-08-03
Chief Tech/Sci/R&D Officer - 2025-07-31
Director TitleAgeSince
Director/Board Member 65 2011-01-31
Director/Board Member 69 2011-03-06
Director/Board Member 56 2012-02-11
Date Insider Type Main position Quantity % Market Cap. Importance
9/30/26 Other

Director

44 0.0001%
9/15/26 Exercice

Head of Human Resources

7,572 0.0108%
9/8/26 Free

Chief Executive Officer

51,798 0.0736%
Change 5-day change 1-year change 3-year change Capi.($)
-1.61%-6.27%+43.98%+10.73% 27.19B
-0.84%-5.09%-19.60%+1.07% 178B
-0.67%-2.84%-1.25%+27.12% 122B
-0.98%+0.12%-15.82%+5.56% 118B
-1.24%-4.25%-42.94%-1.34% 88.1B
-0.63%-5.55%-7.27%+70.54% 64.71B
+0.05%-2.41%+10.41%-9.90% 57.96B
-1.95%-3.98%-6.85%+41.55% 53.28B
-2.91%-4.35%-0.97%+38.45% 47.8B
-1.64%+1.50%+1.30%-2.04% 35.65B
Average -1.24%-2.99%-3.90%+18.17% 79B
Weighted average by Cap. -1.06%-3.08%-10.51%+15.51%

Financials

2026 *2027 *
Net sales 3.42B 3.12B 2.87B 2.61B 4.9B 317B 5.17B 34.97B 13.89B 173B 12.83B 12.56B 542B 3.62B 3.3B 3.04B 2.77B 5.19B 336B 5.48B 37.04B 14.71B 183B 13.59B 13.3B 574B
Net income 666M 608M 559M 509M 955M 61.74B 1.01B 6.81B 2.71B 33.65B 2.5B 2.45B 106B 735M 671M 617M 562M 1.05B 68.15B 1.11B 7.52B 2.99B 37.15B 2.76B 2.7B 117B
Net Debt -499M -455M -419M -381M -715M -46.22B -754M -5.1B -2.03B -25.19B -1.87B -1.83B -79.06B -836M -762M -702M -639M -1.2B -77.44B -1.26B -8.54B -3.39B -42.21B -3.14B -3.07B -132B
Projected Income Statement - Annual - West Pharmaceutical Services, Inc.
Logo West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. specializes in the design, manufacture and marketing of components and systems for the containment and administration of injectable drugs. The group offers packaging, components for syringes, cartridge systems, auto-injection devices, accessories for vials, specialty components, etc. Net sales break down by group of products as follows: - proprietary products (81.1%); - contract-manufactured products (18.9%). At the end of 2025, the group had 25 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (43.2%), Germany (12.4%), Ireland (10.8%), France (7.4%), Europe (14.7%) and other (11.5%).
Employees
10,800
Date Price Change Volume
26-11-20 US$390.30 -1.61% 623,502
26-11-19 US$396.69 -1.81% 819,624
26-11-18 US$404.02 -2.44% 595,823
26-11-17 US$414.12 -0.88% 494,112
26-11-16 US$417.80 +0.33% 526,156
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - West Pharmaceutical Services, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
390.30USD
Average target price
471.00USD
Spread / Average Target
+20.68%